Data Sheet 1_Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms.pdf by Xiaohui Huang (458909)

“…Currently, no standardized therapeutic protocol exists for DSP-MG due to its scarcity and clinical heterogeneity. Herein, we report a case of a 68-year-old female patient with DSP-MG who showed significant clinical improvement during an acute exacerbation after treatment with the FcRn antagonist efgartigimod, following the failure of conventional therapy. …”

Nielsen scanner data trend in discount amount for noncalorically sweetened beverages. by Osama M. El-Sayed (11920046)

Nielsen scanner data trend in discount amount for sugar-sweetened beverages. by Osama M. El-Sayed (11920046)

Influence of the amount of DNA in the low-conductivity droplet on calcein leakage and gene transfection. by Yoshino Tsurusaki (15419063)

Results of false positive report probability analysis for significant findings. by Md. Harun-Or-Roshid (10270803)

Significance test results of the optimized model. by Ying Wang (11406)

Summary of different pairs of significant parameters by accounting for the false discovery rate. by Bedilu Alamirie Ejigu (5236571)

Reported and predicted weekly confirmed cases. by Hiroki Koshimichi (19369838)

Negative binomial models on the weekly drinking amount in Scotland, 2008–2021. by Duyen Thuy Nguyen (10457356)

Subjects:

Reported human ehrlichiosis cases by country. by Larissa Gygax (19321697)

Subjects:

Trends in the amount and proportion of services in Japan. by Yukihiro Sato (2400409)

Subjects:

Lack of <i>Efnb1</i> in POMC-expressing progenitors decreases the amount of glutamatergic inputs into these neurons. by Manon Gervais (9708032)

Image_1_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Image_4_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Table_1_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.docx by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Image_3_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

Image_2_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.jpeg by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”

The number of dengue cases reported from 2018 to 2021. by Dinuka Ariyaratne (721988)

Subjects:

Descriptives of study variables in cases and controls. by Daniella Justesen (22170253)

Subjects:

DataSheet_3_Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases.docx by Nan Wang (21935)

“…</p>Conclusions<p>This case series reports the significant therapeutic effect of pyrotinib on cutaneous metastases of HER2-positive BC for the first time. …”